[The research progress of neutrophil-to-lymphocyte ratio level in chronic obstructive pulmonary disease with lung cancer].

Source: PubMed, NCBI / U.S. National Library of Medicine

The neutrophil-to-lymphocyte ratio (NLR), as a simple and reliable biomarker of systemic inflammation, has garnered significant attention in the clinical management of various inflammatory diseases and malignancies. By quantifying the relative counts of neutrophils and lymphocytes, this parameter reflects the body's immune-inflammatory status. This article provides a comprehensive review of the current research on the role of NLR in chronic obstructive pulmonary disease (COPD) concomitant with advanced lung cancer (LC) and aims to offer insights into novel diagnostic approaches, prognostic evaluation strategies, and potential therapeutic implications for clinical practice.